Disclosure Plus

BioInfra Co.,Ltd. Reports 230 Million Operating Profit in Q2… Returns to Profitability Year-Over-Year

Shin Ha-yeon
2026-07-24 17:32:14
[Edaily Reporter Shin Ha-yeon ] BioInfra Co.,Ltd.(199730)announced on the 24th that its operating profit for the second quarter of this year was 227 million won, marking a return to profitability compared to the same period last year. During the same period, revenue increased by 42.5% to 8.662 billion won, and net income turned to a profit of 152 million won.

Economy

Corporation

IT·Science

Economy

High Interest Rates and Deteriorating Creditworthiness: A ‘Double Whammy’… Warning Signs as 23 Companies Face Rating Downgrades

As the prolonged period of high interest rates increases the refinancing burden on companies, warning signs of credit rating downgrades have emerged, particularly in sectors experiencing sluggish busi…
2026-11-20 16:10:05

Corporation

“100 People Line Up Even in Sub-Zero Temperatures”… Olive Young Launches Second ‘K-Color Cosmetics’ Initiative in Hongdae [Report]

On the streets of Hongdae, where morning temperatures had dropped below freezing, one building was bathed entirely in pink. People wearing down jackets with hoods pulled tight lined up along the wall,…
2026-11-20 16:09:57

IT·Science

Aimed Bio Inc.’s ADC Technology Export Shows 60% Response Rate in Phase 1 Clinical Trial… Moving Forward with U.S. Approval Trials

#Aimed Bio Inc.’s antibody-drug conjugate (ADC) “BHV-1530 (AMB302),” which was licensed to U.S.-based Biohaven, has demonstrated initial anticancer efficacy in a Phase 1 clinical trial. Biohaven plans…
2026-11-20 13:07:02